David Griffiths

7.2k total citations · 1 hit paper
47 papers, 4.9k citations indexed

About

David Griffiths is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, David Griffiths has authored 47 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 22 papers in Infectious Diseases and 15 papers in Microbiology. Recurrent topics in David Griffiths's work include Pneumonia and Respiratory Infections (18 papers), Clostridium difficile and Clostridium perfringens research (17 papers) and Bacterial Infections and Vaccines (14 papers). David Griffiths is often cited by papers focused on Pneumonia and Respiratory Infections (18 papers), Clostridium difficile and Clostridium perfringens research (17 papers) and Bacterial Infections and Vaccines (14 papers). David Griffiths collaborates with scholars based in United Kingdom, France and Australia. David Griffiths's co-authors include Derrick W. Crook, Tim Peto, J. Bates, J. Z. Jordens, Brian G. Spratt, Mark H. Wilcox, A. Sarah Walker, Kate E. Dingle, David W. Eyre and Alison Vaughan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

David Griffiths

46 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing

2013 487 citations David W. Eyre, Madeleine Cule et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by David Griffiths

Since Specialization

Citations

This map shows the geographic impact of David Griffiths's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Griffiths with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Griffiths more than expected).

Fields of papers citing papers by David Griffiths

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Griffiths. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Griffiths. The network helps show where David Griffiths may publish in the future.

Co-authorship network of co-authors of David Griffiths

This figure shows the co-authorship network connecting the top 25 collaborators of David Griffiths. A scholar is included among the top collaborators of David Griffiths based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Griffiths. David Griffiths is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibiotics’ Use in Thailand: Community Pharmacists’ Knowledge, Attitudes and Practices 2021 ·Antibiotics ·(unknown), (unknown), David Griffiths, Saleh Alghamdi	23
2	Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012 2015 ·Eurosurveillance ·David W. Eyre, Lauren Tracey, Briony Elliott, Claudia Slimings, (unknown), Rhonda L. Stuart, Tony M. Korman, George Kotsiou, Rebecca McCann, David Griffiths, Warren N. Fawley, Paul Armstrong, Kate E. Dingle, A. Sarah Walker, Tim Peto, Derrick W. Crook, Mark H. Wilcox, Thomas V. Riley	56
3	Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England 2014 ·The Journal of Infectious Diseases ·Catrin E. Moore, John R. Paul, Dona Foster, Saeed Ahmed Mahar, David Griffiths, Kyle Knox, Tim Peto, Andrew Walker, Derrick W. Crook	67
4	Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile 2013 ·The Journal of Infectious Diseases ·David W. Eyre, Farah Babakhani, David Griffiths, (unknown), Carlos del Ojo Elías, Sherwood L. Gorbach, Tim Peto, Derrick W. Crook, A. Sarah Walker	46
5	Asymptomatic Clostridium difficile Colonisation and Onward Transmission 2013 ·PLoS ONE ·David W. Eyre, David Griffiths, Alison Vaughan, Tanya Golubchik, (unknown), Lily O’Connor, Derrick W. Crook, A. Sarah Walker, Tim Peto	101
6	Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing breakdown → 2013 ·New England Journal of Medicine ·David W. Eyre, Madeleine Cule, Daniel J. Wilson, David Griffiths, Alison Vaughan, Lily O’Connor, Camilla L. C. Ip, Tanya Golubchik, Elizabeth M. Batty, John Finney, David Wyllie, Xavier Didelot, Paolo Piazza, Rory Bowden, Kate E. Dingle, Rosalind M. Harding, Derrick W. Crook, Mark H. Wilcox, Tim Peto, Andrew Walker	487
7	Detection of Mixed Infection from Bacterial Whole Genome Sequence Data Allows Assessment of Its Role in Clostridium difficile Transmission 2013 ·PLoS Computational Biology ·David W. Eyre, Madeleine Cule, David Griffiths, Derrick W. Crook, Tim Peto, A. Sarah Walker, Daniel J. Wilson	61
8	Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection 2013 ·Clinical Infectious Diseases ·A. Sarah Walker, David W. Eyre, David Wyllie, Kate E. Dingle, David Griffiths, Brian Shine, Sarah Oakley, Lily O’Connor, John Finney, Alison Vaughan, Derrick W. Crook, Mark H. Wilcox, Tim Peto	173
9	Microevolutionary analysis of Clostridium difficile genomes to investigate transmission 2012 ·Genome biology ·Xavier Didelot, David W. Eyre, Madeleine Cule, Camilla L. C. Ip, M. Azim Ansari, David Griffiths, Alison Vaughan, Lily O’Connor, Tanya Golubchik, Elizabeth M. Batty, Paolo Piazza, Daniel J. Wilson, Rory Bowden, Peter Donnelly, Kate E. Dingle, Mark H. Wilcox, A Sarah Walker, Derrick W. Crook, Tim Peto, Rosalind M. Harding	157
10	Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management 2012 ·Clinical Infectious Diseases ·David W. Eyre, A. Sarah Walker, David Wyllie, Kate E. Dingle, David Griffiths, Jack W. Finney, Lily O’Connor, Alison Vaughan, Derrick W. Crook, Mark H. Wilcox, Tim Peto	180
11	Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity 2011 ·PLoS ONE ·Kate E. Dingle, David Griffiths, Xavier Didelot, (unknown), Alison Vaughan, Melina Kachrimanidou, Nicole Stoesser, Keith A. Jolley, Tanya Golubchik, Rosalind M. Harding, Tim Peto, Warren N. Fawley, A. Sarah Walker, Mark H. Wilcox, Derrick W. Crook	144
12	School‐Aged Children: A Reservoir for Continued Circulation ofHaemophilus influenzaeType b in the United Kingdom 2008 ·The Journal of Infectious Diseases ·(unknown), David Griffiths, Tessa M. John, Gary Lee, Ly‐Mee Yu, Noel McCarthy, Paul T. Heath, Derrick W. Crook, Mary Ramsay, E. Richard Moxon, Andrew J. Pollard	37
13	Oro‐dental features as useful diagnostic tool in Rubinstein–Taybi syndrome 2007 ·American Journal of Medical Genetics Part A ·Agnès Bloch‐Zupan, (unknown), Dimitris Emmanouil, Benoı̂t Arveiler, David Griffiths, Didier Lacombe	19
14	Capsular Serotype–Specific Attack Rates and Duration of Carriage ofStreptococcuspneumoniaein a Population of Children 2006 ·The Journal of Infectious Diseases ·Karen Sleeman, David Griffiths, Fiona Shackley, Linda Diggle, Sunetra Gupta, Martin Maiden, E. Richard Moxon, Derrick W. Crook, Tim Peto	196
15	Invasive Pneumococcal Disease in England and Wales: Vaccination Implications 2001 ·The Journal of Infectious Diseases ·Karen Sleeman, Kyle Knox, Robert C. George, Elizabeth Miller, Pauline Waight, David Griffiths, Androulla Efstratiou, Karen Broughton, Richard Mayon‐White, E. Richard Moxon, Derrick W. Crook	101
16	Molecular Typing of Bacteria Directly from Cerebrospinal Fluid 2000 ·European Journal of Clinical Microbiology & Infectious Diseases ·Mark C. Enright, Kyle Knox, David Griffiths, Derrick W. Crook, Brian G. Spratt	39
17	Serotype Distribution and Prevalence of Resistance to Benzylpenicillin in Three Representative Populations of Streptococcus pneumoniae Isolates from the Coast of Kenya 1998 ·Clinical Infectious Diseases ·J. Anthony G. Scott, Andy Hall, (unknown), Richard Edwards, (unknown), Brett Lowe, David Griffiths, Derrick W. Crook, Kevin Marsh	50
18	Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. 1998 ·Journal of Clinical Investigation ·Slobodan Vukičević, (unknown), Dunja Rogić, Nikolina Bašić‐Jukić, M. S. Shih, Alyssa Shepard, Dong Chan Jin, (unknown), William K. Jones, Haimanti Dorai, Stephen Ryan, David Griffiths, (unknown), Mislav Jelić, (unknown), A Stavljenić, T. Kuber Sampath	258
19	Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T 1997 ·Archives of Disease in Childhood ·Paul T. Heath, (unknown), David Griffiths, Helen R. Griffiths, Derrick W. Crook, E. Richard Moxon	34
20	Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man 1994 ·Journal of Antimicrobial Chemotherapy ·J. Bates, J. Z. Jordens, David Griffiths	358

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact